Table of Content

1. Report Summary
1.1. Research Methods and Tools
1.2. Pipeline Analysis
1.3. Market Breakdown
1.3.1. By Segments
1.3.2. By Geography
1.3.3. By Stakeholders
1.3.4. Exceptions

2. Market Overview and Insights
2.1. Definition
2.2. Patent Analysis
2.3. Analyst Insights & Current Market Trends
2.3.1. Key Findings
2.3.2. Recommendation
2.3.3. Conclusion
2.4. Regulation
2.4.1.1. United States
2.4.1.2. European Union
2.4.1.3. China
2.4.1.4. India

3. Market Determinant
3.1. Motivators
3.1.1. Increasing Incidence of Nasopharyngeal Cancer
3.1.2. High Tobacco and Alcohol Consumption
3.1.3. High Intake of Salt Preserved Food
3.1.4. Exposure to Epstein-Barr Virus (EBV)
3.2. Restraints
3.2.1. High Cost of Treatment
3.2.2. Low Awareness Toward Cancer
3.2.3. Adverse Effect of Treatment
3.3. Opportunities
3.3.1. Rapid Adoption of Technologies in Healthcare Premises

4. Market Segmentation
4.1. Global Nasopharyngeal Cancer Market, By Cancer Type
4.1.1. Keratinising Squamous Cell Carcinoma
4.1.2. Non-Keratinising Squamous Cell Carcinoma
4.1.3. Undifferentiated Carcinomas
4.1.4. Other (Adenocarcinoma and Adenoid Cystic Carcinomas)
4.2. Global Nasopharyngeal Cancer Market, By Diagnosis Method
4.2.1. Initial Diagnosis
4.2.1.1. Nasendoscopy
4.2.1.2. Panendoscopy
4.2.1.3. Fine Needle Aspiration/Needle Biopsy
4.2.2. Advanced Diagnosis
4.2.2.1. CT Scan
4.2.2.2. PET Scan
4.2.2.3. MRI Scan
4.2.2.4. Bone Scan
4.3. Global Nasopharyngeal Cancer Market, By Therapy
4.3.1. Chemotherapy
4.3.2. Immunotherapy
4.3.3. Surgery
4.3.4. Targeted Therapy


5. Competitive Landscape
5.1. Key Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North American
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.3. APAC
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of APAC
6.4. Rest of The World

7. Company Profiles
7.1. Biodiem Ltd.
7.2. Bristol-Myers Squibb
7.3. Cyclacel Pharmaceuticals Inc.
7.4. Eli Lilly And Co.
7.5. GlaxoSmithKline Plc.
7.6. Merck & Co., Inc.
7.7. Novartis International AG
7.8. Ono Pharmaceutical Co.,
7.9. Safoni
7.10. Theravectys SA



List of Figures


FIGURE # 1 GLOBAL NASOPHARYNGEAL CANCER MARKET SHARE, BY CANCER TYPE, 2017-2023 ($ MILLION)
FIGURE # 2 GLOBAL NASOPHARYNGEAL CANCER MARKET SHARE, BY DIAGNOSTIC METHOD 2017-2023 ($ MILLION)
FIGURE # 3 GLOBAL NASOPHARYNGEAL CANCER MARKET SHARE, BY THERAPY 2017-2023 ($ MILLION)
FIGURE # 4 GLOBAL NASOPHARYNGEAL CANCER MARKET SHARE, BY GEOGRAPHY, 2017-2023 ($ MILLION)
FIGURE # 5 NORTH AMERICA NASOPHARYNGEAL CANCER MARKET SHARE 2017-2023($ MILLION)
FIGURE # 6 UNITED STATES NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 7 CANADA MARKET NASOPHARYNGEAL CANCER RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 8 EUROPE MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
FIGURE # 9 UK NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 10 GERMANY NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 11 SPAIN NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 12 FRANCE NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 13 ITALY NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 14 ROE NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 15 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
FIGURE # 16 CHINA NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 17 INDIA NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 18 JAPAN NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 19 REST OF ASIA PACIFIC (ROAPAC) NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
FIGURE # 20 REST OF WORLD (ROW)NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)

 

List of Tables


TABLE # 1 GLOBAL NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL KERATINISING SQUAMOUS CELL CARCINOMA MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL NON-KERATINISING SQUAMOUS CELL CARCINOMA MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL UNDIFFERENTIATED CARCINOMAS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL OTHER NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL NASOPHARYNGEAL CANCER MARKET, BY DIAGNOSIS METHOD MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL INITIAL NASOPHARYNGEAL CANCER DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL NASENDOSCOPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL PANENDOSCOPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL NASOPHARYNGEAL CANCER NEEDLE BIOPSY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL ADVANCED DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL NASOPHARYNGEAL CANCER CT SCAN MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 13 GLOBAL NASOPHARYNGEAL CANCER PET SCAN MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 14 GLOBAL NASOPHARYNGEAL CANCER MRI SCAN MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 15 GLOBAL NASOPHARYNGEAL CANCER CHEST X-RAY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 16 GLOBAL NASOPHARYNGEAL CANCER BONE SCAN MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 17 GLOBAL NASOPHARYNGEAL CANCER MARKET, BY THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 18 GLOBAL NASOPHARYNGEAL CANCER CHEMOTHERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 19 GLOBAL NASOPHARYNGEAL CANCER IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 20 GLOBAL NASOPHARYNGEAL CANCER CHEMORADIOTHERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 21 GLOBAL NASOPHARYNGEAL CANCER SURGERY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE # 22 NORTH AMERICA NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 23 NORTH AMERICA NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS METHOD 2017-2023 ($ MILLION)
TABLE # 24 NORTH AMERICA NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY THERAPY METHOD 2017-2023 ($ MILLION)
TABLE # 25 NORTH AMERICA NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY COUNTRIES 2017-2023 ($ MILLION)
TABLE # 26 EUROPE NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 27 EUROPE NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS METHOD 2017-2023 ($ MILLION)
TABLE # 28 EUROPE NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY THERAPY METHOD 2017-2023 ($ MILLION)
TABLE # 29 EUROPE NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY COUNTRIES 2017-2023 ($ MILLION)
TABLE # 30 ASIA PACIFIC NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY CANCER TYPE, 2017-2023 ($ MILLION)
TABLE # 31 ASIA PACIFIC NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY DIAGNOSIS METHOD 2017-2023 ($ MILLION)
TABLE # 32 ASIA PACIFIC NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY THERAPY METHOD 2017-2023 ($ MILLION)
TABLE # 33 ASIA PACIFIC NASOPHARYNGEAL CANCER MARKET RESEARCH AND ANALYSIS, BY COUNTRIES 2017-2023 ($ MILLION)